Literature DB >> 18484674

Risk-reducing effect of education in Alzheimer's disease.

Sigrid Botne Sando1, Stacey Melquist, Ashley Cannon, Michael Hutton, Olav Sletvold, Ingvild Saltvedt, Linda R White, Stian Lydersen, Jan Aasly.   

Abstract

OBJECTIVE: To estimate the effect of education on the risk of Alzheimer's disease (AD).
METHODS: 373 patients diagnosed with AD and 559 healthy control individuals without first degree relatives with known dementia, were included in a case-control study (2003-2006). All individuals were genotyped for APOE alleles. Odds ratio (OR) for developing AD was calculated by binary logistic regression, with the number of APOE epsilon 4 alleles and educational level as covariates. Analyses were carried out separately for men and women and for different age groups.
RESULTS: Carriers of one APOE epsilon 4 allele had OR of 4.2, and carriers of two APOE epsilon 4 alleles OR of 12.4 for developing AD. When adjusted for the number of APOE epsilon 4 alleles, OR for developing AD was significantly reduced in participants with 8-9 years of education compared to those with only 6-7 years, and was reduced further for those with 10-18 years of education. These findings were obtained for all the age groups studied and for both men and women.
CONCLUSIONS: Education had a consistently protective effect on the risk of developing clinical AD in a dose-dependent manner in both men and women, and in all age groups, also when adjusting for the number of APOE epsilon 4 alleles. Male gender was protective, probably at least in part because of a higher educational level. Copyright (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18484674     DOI: 10.1002/gps.2043

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  20 in total

1.  Learning induces neurotrophin signaling at hippocampal synapses.

Authors:  Lulu Y Chen; Christopher S Rex; Yas Sanaiha; Gary Lynch; Christine M Gall
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-30       Impact factor: 11.205

Review 2.  Cognitive reserve and Alzheimer's disease.

Authors:  Wei Xu; Jin-Tai Yu; Meng-Shan Tan; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-05-04       Impact factor: 5.590

3.  Trends in the Prevalence and Disparity in Cognitive Limitations of Americans 55-69 Years Old.

Authors:  HwaJung Choi; Robert F Schoeni; Linda G Martin; Kenneth M Langa
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2018-04-16       Impact factor: 4.077

4.  Cognitive Function and Vascular Risk Factors Among Older African American Adults.

Authors:  Ishan C Williams; Moon Ho Park; Siny Tsang; Scott A Sperling; Carol Manning
Journal:  J Immigr Minor Health       Date:  2018-06

5.  Frequent cognitive activity compensates for education differences in episodic memory.

Authors:  Margie E Lachman; Stefan Agrigoroaei; Chandra Murphy; Patricia A Tun
Journal:  Am J Geriatr Psychiatry       Date:  2010-01       Impact factor: 4.105

6.  Psychosocial risk factors and Alzheimer's disease: the associative effect of depression, sleep disturbance, and anxiety.

Authors:  Shanna L Burke; Tamara Cadet; Amary Alcide; Janice O'Driscoll; Peter Maramaldi
Journal:  Aging Ment Health       Date:  2017-10-27       Impact factor: 3.658

Review 7.  Midlife predictors of Alzheimer's disease.

Authors:  B B Bendlin; C M Carlsson; C E Gleason; S C Johnson; A Sodhi; C L Gallagher; L Puglielli; C D Engelman; M L Ries; G Xu; W Wharton; S Asthana
Journal:  Maturitas       Date:  2009-12-30       Impact factor: 4.342

8.  Hypertension and Hypercholesterolemia Modify Dementia Risk in Relation to APOEɛ4 Status.

Authors:  Jagan A Pillai; Lei Kou; James Bena; Lisa Penn; James B Leverenz
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

9.  Geographic variation in Alzheimer's disease mortality.

Authors:  Michael Topping; Jinho Kim; Jason Fletcher
Journal:  PLoS One       Date:  2021-07-01       Impact factor: 3.240

10.  Rivastigmine lowers Aβ and increases sAPPα levels, which parallel elevated synaptic markers and metabolic activity in degenerating primary rat neurons.

Authors:  Jason A Bailey; Balmiki Ray; Nigel H Greig; Debomoy K Lahiri
Journal:  PLoS One       Date:  2011-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.